A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation

Blood

Volumn 91, Issue 9, 1998, Pages 3509-3517

  Bernstein, Steven H ^a,b   Nademanee, Auayporn P ^a   Vose, Julie M ^a   Tricot, Guido ^a   Fay, Joseph W ^a   Negrin, Robert S ^a   DiPersio, John ^a   Rondon, Gabriela ^a   Champlin, Richard ^a   Barnett, Michael J ^a   Cornetta, Kenneth ^a   Herzig, Geoffrey P ^a   Vaughan, William ^a   Geils Jr , George ^a   Keating, Armand ^a   Messner, Hans ^a   Wolff, Steven N ^a   Miller, Kenneth B ^a   Linker, Charles ^a   Cairo, Mitchell ^a   Hellmann, Susan ^a   Ashby, Mark ^a   Stryker, Scott ^a   Nash, Richard A ^a   more..

^a GENENTECH INC   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; HLA DR ANTIGEN;

ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; HEALTH CARE COST; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME;

EID: 0032079442     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.9.3509.3509_3509_3517     Document Type: Article

References (31)

1. Decary F, Ferner P, Giavedoni L, Hartman A, Howie R, Kalovsky E, Laschinger C, Malette H, Martyres A, Mervirt H, Naylor DH, St. Rose JEM, Shepherd SA, Tibensky D: An investigation of nonhemolytic transfusion reactions. Vox Sang 46:277, 1984
2. Slichter SJ: Prevention of platelet alloimmunization, in Murawski K, Peetoom F (eds): Transfusion Medicine: Recent Technological Advances. New York, NY, Liss, 1986, p 83
3. Dodd RY: The risk of transfusion-transmitted infection. N Engl J Med 327:419, 1992
4. Gaydos LA, Freireich EJ, Mantel N: Quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med 266:905, 1962
5. Gmür J, Burger J, Schanz U, Fehr J: Safety of stringent prophylactic platelet transfusion policy for patients with acute leukemia. Lancet 338:1223, 1991
6. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lemer KG, Thomas ED: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18:295, 1974
7. Andrews RG, Singer JW, Bernstein ID: Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67:842, 1986
8. Haas R, Möhle R, Frühauf S, Goldschmidt H, Witt B, Flentje M, Wannenmacher M, Hunstein W: Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787, 1994
9. Bensinger WI, Longin K, Applebaum F, Rowley S, Weaver C, Lilleby K, Gooley T, Lynch M, Higano T, Klarnet J, Chauncey T, Storb R, Buckner CD: Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87:825, 1994
10. Bensinger W, Applebaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, Cliff R, Chauncey T, Klarnet J, Montgomery P, Petersdorf S, Weiden P, Witherspoon R, Buckner CD: Factors that influence collection and engraftment of autologous peripheral-blood stem cells. Blood 13:2547, 1995
11. Weaver CH, Hazelton B, Birch R, Palmer P, Alien C, Schwartzberg L, West W: An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86:3961, 1995
12. Knopse WH: Long term bone marrow damage after irradiation, in Testa NG, Gale RP (eds): Hematopoiesis: Long Term Effects of Chemotherapy and Radiation. New York, NY, Dekker, 1988
13. Beatty PG, Clift RA, Mickelson EM, Nisperos BB, Floumoy N, Martin PJ, Sanders JE, Stewart P, Buckner CD, Storb R, Thomas ED, Hansen JA: Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 313:765, 1985
14. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J, McGlave P, Perkins HA, Phillips GL, Sanders J, Stroncek D, Thomas ED, Blumé KG: Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program. N Engl J Med 328:593, 1993
15. Anasetti C, Rybka W, Sullivan KM, Banaji M, Slichter SJ: Graft-v-host disease is associated with autoimmune-like thrombocytopenia. Blood 43:1054, 1989
16. Nash RA, Gooley T, Davis C, Appelbaum FR: The problem of thrombocytopenia after hematopoietic stem cell transplantation. Stem Cells 14:261, 1996 (suppl 1)
17. Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD, Clift R, Doney K, Martin PJ, Mickelson E, Nisperos B, O'Quigley J, Ramberg R, Sanders JE, Stewart P, Storb R, Sullivan KM, Witherspoon RP, Thomas ED, Hansen JA: Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 320:197, 1989
18. Simmons PJ, Prezepiorka D, Thomas ED, Torok-Storb B: Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 328:429, 1987
19. Poskitt TR, Poskitt KF: Thrombocytopenia of sepsis: The role of circulating IgG-containing immune complexes. Arch Intern Med 145: 981, 1985
20. Cohen P, Gardner FH: Thrombocytopenia as a laboratory sign and complication of gram-negative bacteremic infection. Arch Intern Med 117:113, 1966
21. Norol F, Kuentz M, Cordonnier C, Beaugean F, Haiouin C, Vernant JP, Duedari N: Influence du statut clinique sur l'efficacité transfusionnelle des plaquettes conservées. Rev Fr Transfus Hemobiol 36:427, 1993
22. Rio B, Andreu G, Nicod A, Arrago JP, Dutrillaux F, Samama M, Zittoun R: Thrombocytopenia in venoocclusive disease after bone marrow transplantation or chemotherapy. Blood 67:1773, 1986
23. Nemunaitis J, Meyers JD, Buckner CD, Shannon-orcy K, More M, Shulman H, Bianco JA, Higano CS, Groves E, Storb R, Hansen J, Appelbaum FR, Singer JW: Phase I trial of recombinant human macrophage colony stimulating factor in patients with invasive fungal infections. Blood 78:907, 1991
24. Nash RA, Burstein SA, Storb R, Yang W, Abrams K, Appelbaum FR, Boone T, Deeg J, Durack LD, Schuening FG, McDonough S, Moore P, Nelp WB, Slichter S: Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: Increased destruction of circulating platelets. Blood 86:1765, 1995
25. Nemunaitis J, Rosenfeld CS, Ash R, Freedman MH, Deeg HJ, Appelbaum F, Singer JW, Flomenberg N, Dalton W, Elfenbein GJ, Rifkin R, Rubin A, Agosti J, Hayes FA, Holcenberg J, Shadduck RK: Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation. Bone Marrow Transplant 15:949, 1995
26. Gisselbrecht C, Prentice HG, Bacigalupo A, Biron P, Milpied N, Ruble H, Cunninham D, Legros M, Pico JL, Linch DC, Burnett AK, Scarffe JH, Siegert W, Yver A: Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation. Lancet 343:696, 1994
27. Anasetti C, Anderson G, Appelbaum FR, Buckner CD, Martin PJ, Nemunaitis J, Singer J, Storb R, Sullivan KM, Thomas ED, Hansen JA: Phase III study of rhGM-CSF in allogeneic marrow transplantation from unrelated donors. Blood 82:1799a, 1993 (abstr, suppl 1)
28. + cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells. Blood 84:2920, 1994
29. Henon PR, Liang H, Beck-Wirth G, Eisenmann JC, Lepers M, Wunder E, Kandel G: Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant 9:285, 1992
30. American Bone Marrow Transplant Registry (ABMTR) Newsletter. Vol 3, November 1996
31. Heckman KD, Weiner GJ, Davis CS, Strauss RG, Jones MP, Burns CP: Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/μ1 versus 20,000/μ1. J Clin Oncol 15:1143, 1997